Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

IV midazolam

ApprovedSmall molecule

HHorizon Health Network

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q1 2027

Post-ApprovalNot yet recruiting

Extracorporeal Shockwave Lithotripsy

NCT07368738

Clinical

Trials by Indication[1]

Extracorporeal Shockwave Lithotripsy1 trial

Intravenous Acetaminophen and Ketorolac for Pain Management During Extracorporeal Shockwave Lithotripsy

Not yet recruiting·HHorizon Health Network·Phase 4·NCT07368738·266 enrolled

Sedation1 trial

Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in Neonates

Unknown status·—·Phase 4·NCT02645279·112 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for IV midazolam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — IV midazolam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for IV midazolam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Horizon Health Network company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: HHorizon Health Network

Related News